Detalhe da pesquisa
1.
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Cancer
; 123(7): 1144-1155, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926776
2.
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
Biol Blood Marrow Transplant
; 20(12): 2034-41, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25234438
3.
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
J Immunother Cancer
; 12(4)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604810
4.
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948504
5.
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).
J Clin Oncol
; 40(25): 2913-2923, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442713
6.
Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154).
Clin Dev Immunol
; 2010: 473453, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21253471
7.
Unexpected heterogeneity in oropharyngeal squamous cell tumors.
Nat Genet
; 55(4): 534-535, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016098
8.
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
Leuk Lymphoma
; 59(7): 1666-1671, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29065747
9.
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
J Clin Oncol
; 35(20): 2260-2267, 2017 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475457
10.
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
J Immunother Cancer
; 4: 92, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031820
11.
Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo.
Cancer Gene Ther
; 12(6): 540-51, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15678150
12.
An introduction to foundation and industry-sponsored research: practical and ethical considerations.
Hematology Am Soc Hematol Educ Program
; : 498-503, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18024671
13.
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide.
Cancer Immunol Immunother
; 55(9): 1033-42, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16283303
14.
Distinct cytokine patterns exist in peripheral blood mononuclear cell cultures of patients with prostate cancer.
Clin Immunol
; 117(1): 94-9, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16027040
15.
Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer.
Cancer Immunol Immunother
; 51(5): 263-70, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12070713